|
⚲
|
| Keyboard |
| Venrock Associates III LP
✚
|
|
|---|---|
| CIK # | 0001119517 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001119517] | |
| 4 | [0001119517] | |
| SC 13D | [0001119517] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Venrock Associates III LP | Vitae Pharmaceuticals Inc | [2014-10-10] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vitae Pharmaceuticals Inc VTAE
Series A-2 Preferred Stock · derivative
|
2014-09-29 | Conversion | 3,563 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 227,117 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 1,009,414 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 25,233 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 9,285 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 41,270 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 1,031 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Buy | 139,019 | $8.00 | 1,112,152 |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 214,820 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 48,333 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Buy | 15,446 | $8.00 | 123,568 |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Buy | 617,868 | $8.00 | 4,942,944 |
|
Vitae Pharmaceuticals Inc VTAE
Series B Preferred Stock · derivative
|
2014-09-29 | Conversion | 25,233 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series B Preferred Stock · derivative
|
2014-09-29 | Conversion | 1,009,414 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series B Preferred Stock · derivative
|
2014-09-29 | Conversion | 227,117 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series C Preferred Stock · derivative
|
2014-09-29 | Conversion | 1,031 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series A-2 Preferred Stock · derivative
|
2014-09-29 | Conversion | 142,607 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series A-2 Preferred Stock · derivative
|
2014-09-29 | Conversion | 32,086 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series C Preferred Stock · derivative
|
2014-09-29 | Conversion | 41,270 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series C Preferred Stock · derivative
|
2014-09-29 | Conversion | 9,285 | $0.00 | |
| showing 20 of 40 most recent transactions | |||||